Duality Biotherapeutics, Inc. (HKG:9606)

Duality Biotherapeutics Statistics

Total Valuation

HKG:9606 has a market cap or net worth of HKD 27.64 billion. The enterprise value is 23.66 billion.

Market Cap	27.64B
Enterprise Value	23.66B

Important Dates

The next estimated earnings date is Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:9606 has 88.04 million shares outstanding.

Current Share Class	88.04M
Shares Outstanding	88.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.02%
Owned by Institutions (%)	23.45%
Float	37.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.62
PB Ratio	8.66
P/TBV Ratio	8.78
P/FCF Ratio	36.41
P/OCF Ratio	36.19
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.63
EV / Sales	9.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	31.16

Financial Position

The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.02.

Current Ratio	4.73
Quick Ratio	4.66
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.10
Interest Coverage	-304.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-6.36%
Revenue Per Employee	12.45M
Profits Per Employee	-16.24M
Employee Count	170
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:9606 has paid 11.28 million in taxes.

Income Tax	11.28M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	353.03
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.95
Average Volume (20 Days)	2,069,922

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9606 had revenue of HKD 2.38 billion and -3.10 billion in losses. Loss per share was -124.82.

Revenue	2.38B
Gross Profit	883.05M
Operating Income	-230.79M
Pretax Income	-3.09B
Net Income	-3.10B
EBITDA	-225.66M
EBIT	-230.79M
Loss Per Share	-124.82

Balance Sheet

The company has 4.06 billion in cash and 74.40 million in debt, giving a net cash position of 3.99 billion or 45.30 per share.

Cash & Cash Equivalents	4.06B
Total Debt	74.40M
Net Cash	3.99B
Net Cash Per Share	45.30
Equity (Book Value)	3.19B
Book Value Per Share	36.25
Working Capital	3.53B

Cash Flow

In the last 12 months, operating cash flow was 763.93 million and capital expenditures -4.80 million, giving a free cash flow of 759.13 million.

Operating Cash Flow	763.93M
Capital Expenditures	-4.80M
Free Cash Flow	759.13M
FCF Per Share	8.62

Margins

Gross margin is 37.13%, with operating and profit margins of -9.70% and -130.43%.

Gross Margin	37.13%
Operating Margin	-9.70%
Pretax Margin	-129.96%
Profit Margin	-130.43%
EBITDA Margin	-9.49%
EBIT Margin	-9.70%
FCF Margin	31.92%

Dividends & Yields

HKG:9606 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-11.22%
FCF Yield	2.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9606 has an Altman Z-Score of 8.26 and a Piotroski F-Score of 2.

Altman Z-Score	8.26
Piotroski F-Score	2